tirzepatide banned by fda Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down GLP-1 compounding while @martymakary is photographed holding bootleg # Zepbound® vs. Compounded Tirzepatide: Key

2 Why GLP-2 Matters Promotes intestinal growth Reduces inflammation Supports intestinal repair and regeneration Potential applications across GI and rare diseases Currently in global Phase II development for Short Bowel Syndrome (SBS) Unlike GLP-1 therapies that focus on metabolic regulation, GLP-2 targets intestinal health and nutrient absorption, addressing significant unmet needs in gastrointestinal disorders

These changes are usually not as strong as the effects of statins, but they can still be helpfulespecially for people who are overweight or have type 2 diabetes

Studies have shown that people who use GLP-1 medications lose a significant amount of weight over time, usually 15-20% of their body weight in a year

At full maintenance doses, semaglutide levels are similar between the Wegovy 25 mg daily tablet and the 2.4 mg weekly injection in adults

Past research has also indicated that these weight loss drugs can help lower a person's risk of cancer as well as provide benefits to heart health and brain health